Transcriptomic Profiling Identifies Ferroptosis-Related Gene Signatures in Ischemic Muscle Satellite Cells Affected by Peripheral Artery Disease—Brief Report
- 1 October 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (10) , 2023-2029
Abstract
BACKGROUND: We hypothesized that transcriptomic profiling of muscle satellite cells in peripheral artery disease (PAD) would identify damage-related pathways contributing to skeletal muscle myopathy. We identified a potential role for ferroptosis—a form of programmed lytic cell death by iron-mediated lipid peroxidation—as one such pathway. Ferroptosis promotes myopathy in ischemic cardiac muscle but has an unknown role in PAD. METHODS: Muscle satellite cells from donors with PAD were obtained during surgery. cDNA libraries were processed for single-cell RNA sequencing using the 10X Genomics platform. Protein expression was confirmed based on pathways inferred by transcriptomic analysis. RESULTS: Unsupervised cluster analysis of over 25 000 cells aggregated from 8 donor samples yielded distinct cell populations grouped by a shared unique transcriptional fingerprint. Quiescent cells were diminished in ischemic muscle while myofibroblasts and apoptotic cells were prominent. Differential gene expression demonstrated a surprising increase in genes associated with iron transport and oxidative stress and a decrease in GPX4 (glutathione peroxidase 4) in ischemic PAD-derived cells. Release of the danger signal HMGB1 (high mobility group box-1) correlated with ferroptotic markers including surface transferrin receptor and were higher in ischemia. Furthermore, lipid peroxidation in muscle satellite cells was modulated by ferrostatin, a ferroptosis inhibitor. Histology confirmed iron deposition and lipofuscin, an inducer of ferroptosis in PAD-affected muscle. CONCLUSIONS: This report presents a novel finding that genes known to be involved in ferroptosis are differentially expressed in human skeletal muscle affected by PAD. Targeting ferroptosis may be a novel therapeutic strategy to reduce PAD myopathy.Keywords
This publication has 44 references indexed in Scilit:
- Human skeletal muscle fibroblasts, but not myogenic cells, readily undergo adipogenic differentiationJournal of Cell Science, 2013
- Inhibiting myostatin reverses muscle fibrosis through apoptosisJournal of Cell Science, 2012
- Sprouty1 Regulates Reversible Quiescence of a Self-Renewing Adult Muscle Stem Cell Pool during RegenerationCell Stem Cell, 2010
- Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory FunctionAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Autophagy regulates selective HMGB1 release in tumor cells that are destined to dieCell Death & Differentiation, 2008
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer CellsChemistry & Biology, 2008
- The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial DysfunctionVascular and Endovascular Surgery, 2008
- The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusionJournal of Experimental Medicine, 2005
- Lipofuscin and Aging: A Matter of Toxic WasteScience of Aging Knowledge Environment, 2005
- Cellular and Molecular Regulation of Muscle RegenerationPhysiological Reviews, 2004